Short vs long radiotherapy before surgery for advanced rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two different schedules of radiation therapy given before surgery for advanced rectal cancer. The goal is to find out if a shorter course of radiation works as well as the longer course, with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with advanced rectal cancer that has not spread to distant organs.
- Your tumor is within about 6 inches of the anal opening.
- You are well enough to undergo radiation and surgery (ECOG score 0-2).
- Your blood counts and kidney/liver function are within a safe range.
- You have not had radiation or chemotherapy for rectal cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different radiation therapy schedules for rectal cancer that hasn't spread to distant sites. Researchers want to see if a shorter treatment plan works as well as a longer one, potentially reducing side effects and treatment time.
This study compares two different schedules of radiation (a short course versus a longer course) followed by standard chemotherapy and immunotherapy for advanced rectal cancer. It aims to see which approach works best to shrink the tumor before surgery.
This trial tests a short course of radiation given before chemotherapy for people with locally advanced rectal cancer (cancer that has grown into nearby tissue and/or nearby lymph nodes but can still be removed). It may help shrink the tumor and make treatment more effective while assessing how well this approach works.
This trial tests giving targeted radiation, chemotherapy, and immunotherapy before surgery to shrink locally advanced rectal cancer. It aims to improve treatment results for patients whose tumors have not spread but are at high risk of coming back.
This trial tests a new way of giving radiation therapy before surgery for rectal cancer. It uses a higher dose to the tumor during standard radiation to see if it can improve outcomes.
This trial tests a shorter course of radiation combined with chemotherapy and immunotherapy before surgery for high-risk rectal cancer. The goal is to see if this combination shrinks the tumor more effectively and improves outcomes.
Hear when a new Adenocarcinoma of the Rectum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.